Incredible Portfolio Despite Deteriorating Culture - R&D bei AstraZeneca: Mitarbeiterbewertung

2,0
14. Sept. 2023
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good compensation, amazing portfolio supported by thousands of talented and engaged professionals

Kontras

A disdainful attitude by senior leadership towards their employees and a top down culture that rewards yes men and discourages people that constructively communicate challenges/risks.

Mehr Bewertungen zu AstraZeneca entdecken

5,0
25. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good products, great oncology pipeline

Kontras

Global leaders moving to US that have limited understanding of US environment

4,0
29. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Lots to learn with multiple launches and focus on AI

Kontras

heavy middle layer slows down decision making

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle